Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies.
about
Orphan Nuclear Receptor NR4A1 Binds a Novel Protein Interaction Site on Anti-apoptotic B Cell Lymphoma Gene 2 Family Proteins.Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax.BCL-2 as therapeutic target for hematological malignancies.
P2860
Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies.
@en
type
label
Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies.
@en
prefLabel
Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies.
@en
P2093
P2860
P1476
Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies.
@en
P2093
Jane Huang
John C Reed
Wayne Fairbrother
P2860
P304
P356
10.1586/17474086.2015.1026321
P577
2015-04-25T00:00:00Z